Viking Therapeutics, Inc. (VKTX)
26.38
-0.33
(-1.24%)
USD |
NASDAQ |
Oct 21, 16:00
26.43
+0.05
(+0.19%)
After-Hours: 20:00
Viking Therapeutics Net Income (Annual) : -359.64M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -359.64M |
| December 31, 2024 | -109.96M |
| December 31, 2023 | -85.90M |
| December 31, 2022 | -68.87M |
| December 31, 2021 | -54.99M |
| December 31, 2020 | -39.50M |
| December 31, 2019 | -25.78M |
| Date | Value |
|---|---|
| December 31, 2018 | -22.06M |
| December 31, 2017 | -20.58M |
| December 31, 2016 | -14.73M |
| December 31, 2015 | -23.40M |
| December 31, 2014 | -21.88M |
| December 31, 2013 | -0.1462M |
| December 31, 2012 | -0.111M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Eli Lilly & Co. | 20.64B |
| Regeneron Pharmaceuticals, Inc. | 4.505B |
| Vertex Pharmaceuticals, Inc. | 3.953B |
| Ironwood Pharmaceuticals, Inc. | 24.02M |
| Compass Therapeutics, Inc. | -66.49M |